(S)-2,4-Diphenyl-4,5-dihydrooxazole>98.0%(GC)5g

(3-METHYLPYRIDAZIN-4-YL)METHANOL, 95.0%, 1g

2-{[5-(methoxymethyl)-2-furoyl]amino}benzoic acid, 95.0%, 1g

(E)-Methyl 4-(2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)vinyl)benzoate, 98%, 250mg

4-[3,5-BIS(TRIFLUOROMETHYL)PHENOXY]BENZYLLAMINE, 95.0%, 100mg

Hexyl b-D-glucopyranoside, 95.0%, 250mg

METHYL 3-IODO-4-(2,2,2-TRIFLUOROACETAMIDO)BENZOATE, 95.0%, 500mg

(S)-4-ISOPROPYL-2-(5-(TRIFLUOROMETHYL)PYRIDIN-2-YL)-4,5-DIHYDROOXAZOLE, 98%, 1g

Ethyl 1-(4-Fluorophenyl)-5-methyl-1H-pyrazole-4-carboxylate, 98.0%, 5g

2-(3-(Methylsulfonamido)phenyl)acetic acid, 95.0%, 5g

3-Bromo-5-methyl-2-(methylthio)pyridine, 97%, 5g

Centrifuge filter unit Ultrafree Ultrafree-MC, PVDF membrane, sample volume up to 0.5 ml, 0,22 µm, Non-sterile, 25 Piece(s)

2,2-Difluoropentanoic acid, 95.0%, 250mg